Financhill
Back

Apellis Pharmaceuticals Vs. Nektar Therapeutics Industry Stock Comparison

Sell
36

APLS
Apellis Pharmaceuticals

Last Price:
$19.46
Seasonality Move:
-18.71%
Buy
56

NKTR
Nektar Therapeutics

Last Price:
$24.96
Seasonality Move:
3.38%
Sell
36
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $19.44. The Score for APLS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $25.01. The Score for NKTR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $19.44
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $25.01
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 59.04 Buy
Chaikin Money Flow: 978928 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.71 - 19.21) Buy
Bollinger Bands (100): (17.13 - 24.01) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.41 Buy
Relative Strength Index (14 RSI): 65.9 Buy
Chaikin Money Flow: -64604 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.5 - 25.8) Buy
Bollinger Bands (100): (7.55 - 17.95) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.43 Buy
20-day SMA: 18.24 Buy
50-day SMA: 18.24 Buy
200-day SMA: 25.42 Sell
8-day EMA: 18.68 Buy
20-day EMA: 18.39 Buy
50-day EMA: 18.83 Buy
200-day EMA: 25.83 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.32 Buy
20-day SMA: 19.57 Buy
50-day SMA: 14.05 Buy
200-day SMA: 14.55 Buy
8-day EMA: 15.41 Buy
20-day EMA: 7.97 Buy
50-day EMA: 3.56 Buy
200-day EMA: 0.94 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.22 per share, and an increase next year of $0.74 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.86 per share, and an increase next year of $0.01 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):